Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five

Veradermics Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 282.1% to $100.31M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryLiquidity

SignalContext dependent

VolatilityStable

First reportedQ4 2025

Last reportedQ1 2026

How to read this metric

Provides visibility into medium-term cash flow availability from the investment portfolio.

Detailed definition

This metric represents the fair value of debt securities in the available-for-sale portfolio maturing between one and fi...

Peer comparison

Standard maturity profile disclosure for utilities with structured investment portfolios.

Metric ID: other_available_for_sale_securities_debt_maturities_afte_540252

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$26.25M	$100.31M
QoQ Change	—	+282.1%

Range$26.25M – $100.31M

Frequently Asked Questions

What is Veradermics 's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five?: Veradermics (MANE) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five of $100.31M in Q1 2026.
What does debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five mean?: The value of debt investments that will mature between one and five years from now.